Newsletter Signup | Join Community
Research survey for CLL and SLL patients - $100 compensation.
FDA Expands Approval of Imbruvica® to Include Initial Treatment for Chronic Lymphocytic Leukemia & Small Cell Lymphoma
ASCO updated reports Calquence has "clinically meaningful" benefit in CLL and may avoid some BTK associated side effects
Venclexta Imbruvica or Rituxan combination therapy appears more promising than single agent treatment.
CLL patients are at increased risk of developing a new cancer including those taking Ibrutinib & BTK Inhibitors
Zydelig® combined with Treanda and Rituxan is and effective treatment of Chronic Lymphocytic Leukemia
CLL is treated with chemotherapy, precision medicines and most recently with CAR T, now with remissions of > 8 years.
considering CAR T for ALL - anyone been through it yet?
looking for others to share their experience with stem cell transplant for leukemia.